Breaking News, Financial News

Financial Report: Teva

Branded revenues up 37%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Teva 2Q Revenues: $5.0 billion (+19%) 2Q Earnings: $863 million (+50%) YTD Revenues: $10.1 billion (+22%) YTD Earnings: $1.7 billion (+27%) Comments: Revenues in the U.S. in the quarter were $2.5 billion (representing 49% of total revenues), up 28%. Revenues in Europe were flat at $1.5 billion, or 30% of total revenues. Rest of the World (ROW) revenues were $1.1 billion (21% of total revenues), up 30%. Generic revenues were $2.6 billion, up 9%. Branded revenues were $1.9 billion, up 37%, pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters